CuraGen Corp. will close its pilot manufacturing plant, effective July 27, 2007. As a result, the company will reduce its workforce by approximately 40 employees, primarily composed of preclinical and manufacturing researchers, and additional support staff from within the organization. CuraGen previously announced that it would make reductions in early-stage and preclinical drug discovery and decreased emphasis on internal manufacturing capabilities. The pilot facility, also known as the Biop...